Last reviewed · How we verify

NCT06962878

Assessment of Bone Volume Changes in Immediate Implant Placement Using Allograft Versus Xenograft in Mandibular Molars

Not yet recruiting NA Last updated 6 August 2025
What this trial tests

NA trial testing Xenograft in Bone Volume in 20 participants. Not yet recruiting.

Timeline
5 August 2025
Primary endpoint
5 February 2026
5 March 2026

Quick facts

Lead sponsorCairo University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date5 August 2025
Primary completion5 February 2026
Estimated completion5 March 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 25 to 40, any sex, with Bone Volume or Immediate Implant With Bone Graft. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Twenty recruited patients indicated for immediate implant placement in mandibular molar sites are divided into two groups, with each group containing ten patients. One group assigned for placement of xenograft after molar extraction and immediate implant placement, while the other group received allograft as space-filling material.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Xenograft

Trials testing the same drug.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06962878.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing